Diuretics in combination antihypertensive therapy: focus on forecast
Abstract
In the modern therapy of arterial hypertension (AH) along with thiazide diuretics b-blockers, calcium antagonists, angiotensin converting enzyme inhibitors and angiotensin receptor blockers are considered for initial and maintenance of antihypertensive therapy in the form of mono - or combination therapy. Five of these classes of drugs have comparable antihypertensive effectiveness and proven impact on prognosis in accordance with the results of randomized controlled clinical trials. The most widely used in clinical practice for the treatment of patients with AH received thiazide diuretics. The most powerful evidence base among the diuretics in regards to the effect on prognosis is chlortalidone. The article presents data from a randomized, placebo-controlled and comparative studies сhlortalidone and hydrochlorothiazide in AH. It is shown that diuretics are the most effective component of combination therapy. The application of a new fixed combination сhlortalidone in combination with azilsartan medoxomil in our country will improve opportunities for effective treatment of this category of patients.
About the Authors
I. E. Chazova
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
T. V. Martyniuk
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
References
1. Чазова И.Е., Ратова Л.Г., Бойцов С.А., Небиеридзе Д.В. Диагностика и лечение артериальной гипертензии (Рекомендации Российского медицинского общества по артериальной гипертониии Всероссийского научного общества кардиологов)//Системные гипертензии. 2010; 7 (3): 5-26.
2. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-357.
3. Леонова М.В., Штейнберг Л.Л., Белоусов Д.Ю. и др. Результаты фармакоэпидемиологического исследования артериальной гипертонии ПИФАГОР IV: приверженность врачей. РМЖ. 2015; 1 (117): 59-66.
4. Леонова М.В., Белоусов Д.Ю., Штейнберг Л.Л. и др. Анализ врачебной практики проведения антигипертензивной терапии в России (по данным исследования ПИФАГОР III). Фарматека. 2009; 2: 98-103.
5. Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность факторов риска сердечно - сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014; 10: 4-12.
6. Veterans Administration Cooperative Study on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. JAMA 1967; 202: 116-22.
7. SHEP Cooperative Research Study Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255-64.
8. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high - risk hypertensive patients randomized to angiotensin - converting enzyme inhibitor or calcium - channel blocker vs diuretic: The Antihypertensive an Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.
9. Peterzan M.A, Hardy R, Chaturvedi N, Hughes A.D. Meta - analysis of dose - response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension 2012; 59: 1104-9.
10. Psaty B.M, Lumley T, Furberg C.D et al. Health outcomes associated with various antihypertensive therapies used as first - line agents: a network meta - analysis. JAMA 2003; 289: 2534-44.
11. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: Effects of various classes of antihypertensive drugsoverview and meta - analyses. J Hypertens 2015; 33 (2): 195-211.
12. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial: Risk factor changes and mortality results. JAMA 1982; 248: 1465-77.
13. Carter B.L, Ernst M.E, Cohen J.D. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004; 43: 4-9.
14. Кurtz T.W. Chlorthalidone: don’t call it “thiazide - like” anymore. Hypertension 2010; 56: 335-7.
15. Liebson P.R, Grandits G.A, Dianzumba S et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional - hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91 (3): 698-706.
16. Materson B.J, Oster J.R, Michael U.F et al. Dose response to chlorthalidone in patients with mild hypertension, efficacy of a lower dose. Clin Pharmacol Ther 1978; 24: 192-8.
17. Khosla N, Chua D.Y, Elliott W.J, Bakris G.L. Are chlorthalidone and hydrochlorothiazide equivalent blood - pressure - lowering medications? J Clin Hypertens (Greenwich) 2005; 7 (6): 354-6.
18. Musini V, Nazer M, Bassett K et al. Blood pressure - lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database Syst Rev 2014; 5: CD003824; doi: 10.1002/14651858.CD003824.pub2.
19. Недогода С.В. Азилсартан: расширит ли он возможности лечения артериальной гипертензии? Кардиология. 2015: 4: 97-100.
20. Bakris G, Sica D, White W.B et al. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil. Am J Med 2012; 125: 1229. e1-1229.e10.
21. Calhoun D.A, Jones D, Textor S et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510-e526.
Review
For citations:
Chazova I.E., Martyniuk T.V. Diuretics in combination antihypertensive therapy: focus on forecast. Systemic Hypertension. 2016;13(2):6-10. (In Russ.)
Views:
170
Email this article 